List of Contents

Liposome Drug Delivery Market Size, Share, and Trends 2024 to 2034

The global liposome drug delivery market size surpassed USD 5.13 billion in 2023 and is estimated to increase from USD 5.59 billion in 2024 to approximately USD 13.12 billion by 2034. It is projected to grow at a CAGR of 8.91% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 4969
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Liposome Drug Delivery Market 

5.1. COVID-19 Landscape: Liposome Drug Delivery Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Liposome Drug Delivery Market, By Liposome Structure

8.1. Liposome Drug Delivery Market Revenue and Volume, by January, 2024-2034

8.1.1. Unilamellar Liposome

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Small

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Large

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

8.1.4. Multilamellar Liposome

8.1.4.1. Market Revenue and Volume Forecast (2021-2034)

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Liposome Drug Delivery Market, By Product

9.1. Liposome Drug Delivery Market Revenue and Volume, by Product, 2024-2034

9.1.1. Liposomal Doxorubicin

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Liposomal Paclitaxel

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Liposomal Amphotericin B

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

9.1.4. Others

9.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Liposome Drug Delivery Market, By Technology 

10.1. Liposome Drug Delivery Market Revenue and Volume, by Technology, 2024-2034

10.1.1. Stealth Liposome Technology

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Non-PEGylated Liposome Technology

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. DepoFoam Liposome Technology

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Liposome Drug Delivery Market, By Application

11.1. Liposome Drug Delivery Market Revenue and Volume, by Application, 2024-2034

11.1.1. Fungal Disease

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Pain Management

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

11.1.3. Cancer Therapy

11.1.3.1. Market Revenue and Volume Forecast (2021-2034)

11.1.4. Viral Vaccine

11.1.4.1. Market Revenue and Volume Forecast (2021-2034)

11.1.5. Photodynamic Therapy

11.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Liposome Drug Delivery Market, By End-User

12.1. Liposome Drug Delivery Market Revenue and Volume, by End-User, 2024-2034

12.1.1. Hospitals

12.1.1.1. Market Revenue and Volume Forecast (2021-2034)

12.1.2. Specialty Centers

12.1.2.1. Market Revenue and Volume Forecast (2021-2034)

12.1.3. Ambulatory Surgical Centers

12.1.3.1. Market Revenue and Volume Forecast (2021-2034)

12.1.4. Others

12.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 13. Global Liposome Drug Delivery Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.1.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.1.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.1.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.6.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.1.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.6.5. Market Revenue and Volume Forecast, by End-User (2021-2034) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.1.7.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.7.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.1.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.7.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.2.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.4. Market Revenue and Volume Forecast, by Application (2021-2034) 

13.2.5. Market Revenue and Volume Forecast, by End-User (2021-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.2.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.6.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.7. Market Revenue and Volume Forecast, by Application (2021-2034) 

13.2.8. Market Revenue and Volume Forecast, by End-User (2021-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.2.9.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.9.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.10. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.11. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.2.12.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.12.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.12.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.13. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.2.14.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.14.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.2.14.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.15. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.3.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.3.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.6.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.7. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.3.8.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.8.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.9. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.3.10.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.10.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.10.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.10.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.3.11.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.11.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.3.11.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.11.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.4.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.6.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.7. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.4.8.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.8.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.9. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.4.10.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.10.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.10.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.10.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.4.11.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.11.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.4.11.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.11.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.5.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.6.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.5.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.7. Market Revenue and Volume Forecast, by End-User (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by January (2021-2034)

13.5.8.2. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.8.3. Market Revenue and Volume Forecast, by Technology (2021-2034)

13.5.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.8.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

Chapter 14. Company Profiles

14.1. Johnson & Johnson Services, Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Gilead Sciences, Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Sun Pharmaceutical Industries Ltd.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Novartis AG

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Teva Pharmaceutical Industries Ltd

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Janssen Pharmaceuticals, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. CELSION Corporation

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Abbott

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Ipsen Pharma

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Spectrum Pharmaceuticals, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us